Skip to main content
Clinical Trials/TCTR20190421001
TCTR20190421001
Recruiting
Phase 4

Relapse Rate and the Clinical Risk Factors Affecting on the Treatment of Graves’ disease at Charoenkrung Pracharak Hospital

Charoenkrung Pracharak Hospital0 sites295 target enrollmentStarted: April 21, 2019Last updated:

Overview

Phase
Phase 4
Status
Recruiting
Enrollment
295

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
0 N/A (No limit) to 0 N/A (No limit) (—)
Sex
All

Inclusion Criteria

  • Patients with Graves’ disease
  • Thai populations

Exclusion Criteria

  • Thyroid storm
  • Antithyroid drugs hypersensitivity reaction
  • Post\-radioactive iodine therapy
  • Post\-thyroidectomy
  • Loss followed\-up before remission
  • Died before remission

Investigators

Similar Trials